Zhejiang Hisoar Pharmaceutical Co., Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,188.867 million compared to CNY 1,307.832 million a year ago. Operating income was CNY 72.233 million compared to CNY 319.565 million a year ago. Net income was CNY 60.506 million compared to CNY 265.595 million a year ago. Basic earnings per share from continuing operations was CNY 0.04 compared to CNY 0.16 a year ago.